Status:
NOT_YET_RECRUITING
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
Lead Sponsor:
Assiut University
Conditions:
Non-alcoholic Fatty Liver Disease
Eligibility:
All Genders
19-60 years
Brief Summary
The validity of laboratory biomarkers in the diagnosis of NAFLD is still not established, and adherence to a healthy dietary lifestyle for those patients in our community is not well studied.
Detailed Description
Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive hepatic fat accumulation, associated with insulin resistance, and defined as the histological presence of steatosis in \>5% hepa...
Eligibility Criteria
Inclusion
- All adult patients attending outpatient clinics characterized by an age over 18 years.
- Patients diagnosed as NAFLD.
Exclusion
- Patients younger than 18 years old.
- Patients diagnosed with viral hepatitis to avoid other causes of liver fibrosis. .
- Patients with alcoholic fatty liver (more than three standard drinks per day for men or more than two standard drinks per day for women).
- Patients receiving treatment with drugs known to promote liver steatosis (for example, tamoxifen, amiodarone, estrogen, or corticosteroids).
- Patients with malignant tumors or other severe organ dysfunction diseases.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06908122
Start Date
April 1 2025
End Date
April 1 2026
Last Update
April 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.